Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FDA TO ANNOUNCE TOUGHER STANDARDS FOR A CORONAVIRUS VACCINE THAT MAKE IT UNLIKELY ONE WILL BE CLEARED BY ELECTION DAY --WASHINGTON POST
Likewise. Especially with this market... too many opportunities to be tied up on a binary event. Not a big fan of betting it all on black.
Smart move... I’ve dropped half my stake... NP is the reason long term.
Great product, poor execution. FDA is a mess no doubt but other companies are making headway with lesser products.
Today is not a day to sell...
Buy LOW, sell high.
Gotta see how the LOI plays out... the upside is extreme compared to the current pps.
As do I. I have 250k shares of Paso in a 401k.
Doubtful... LNG powered shipping fleet could double this decade https://www.rt.com/business/501278-lng-powered-shipping-fleet-double/
FDA is way behind... at least they are admitting they screwed up the therapeutics.
Lol, it’s not my failure... so no need to make excuses.
Just watching the trading action. It’s obvious Paso choked and shorts are feasting like always.
Interesting quote from ex FDA commish...
https://endpts.com/celltrion-to-begin-mass-producing-antibody-treatment-before-getting-approval/
But that’s the NP hype... dilutes the effort and provides the next bait for investing. No need to close out an indication... just keep the hype fueled.
Here’s an idea... close out HIV and Covid first...
Lol... the OTC is super annoying. But JG has to learn to ignore. I guess he hasn’t learned that yet.
Nah, TBD. FDA dragging this out til 2021 but other countries are moving faster. Pay attention
Agreed, it’s long been known that CYDY has to go international.
Looking good on that path.
Which is 10x more than the medical community and the FDA.
Gotta monetize that knowledge
Nah, shorts have to cover today. Look at the message board. They always drop in to support their cause. Obvious.
Dilution might happen post RMA.
HGEN winning the race with an inferior product to LL. Reverse split was smart.
Amazing that NP can’t win this with LL, slam dunk.
Coordinated short attack to get out before the divvy date. Short positions must be closed.
Too bad we don’t have news... lol. They’d get squeezed so hard. Oh well.
This is well said and spot on narrative of current events. We have a rookie C suite and it shows.
Agreed on all. Confidence in status quo is weak.
Yeah, but if NP fails and leaves and they hire a new CEO they could right the ship. I’m sure you’ve been around long enough to see magic when leadership is changed for the better.
Point being if NP fails hard in 2020 not all hope is lost if they can find a CEO that can “collaborate”. That’s the beauty of having a great product.
If they fail at Covid and HIV then it’ll be lucky to hold $1. Obvious but true.
They need to hire a savvy CEO. But I’d give NP til end of 2020. If he can’t get it done then cya.
Market doesn’t like the Divvy?
Another hit piece? Sykes was all over it as soon as it happened.
This stock is becoming a joke lately.
Yep, down low, not chasing the hype. Might sell into it... always take profits.
Like most bag holders... oops.
Those who have been around VYST for years know when to buy... just review the charts
It proved that NP is yet again hyping and does not understand the process.
If you don’t know the quote... be careful... you might lose your rent.
Now there’s some data... well done. Two weeks and we’ll know.
Right.... many bought at a dime...
Lots of new bag holders... peeps will be doing personal pumps trying to salvage cash.
History is proving that correct
You’re right I don’t need him to provide a timeline ... but he did and it didn’t happen.
More of the same with NP, hype and strikeouts... when will he learn.
Ok, well it’s mid-Sept so... No uplist.
They really need to stop hyping and missing.
Negative. Been at it for 20 years. It’s nice.
Sure, you can uplist without revs. But if they could it would’ve happened by now per NP timeline.
Saunders is professional and timely on his responses. However, he does not know what Chas is up to specifically.
As for him being positive, he doesn’t have any other choice. The other choices would be a detriment to the already extremely poor shareholder consensus.
Also the self evaluation of the company going into the divvy date.
NP Timeline for Naz has expired. Either they didn’t apply or they were denied. No Naz until they get revs
Maybe after Covid has passed the FDA will consider it. They are too busy with Covid to consider any Covid cures.
Did he? NP still on the outside looking in burning cash and selling shares.
Being cooperative with the FDA and power players during a pandemic is the right thing to do even though it’s largely symbolic. It gets free pub and likely a EUA with accompanying revenues.
Hard to win at poker if they won’t let you sit down. NP declined the chair... now he’s looking for JV tables to regain the previously offered chair.
Rookie arrogant mistake. Predictable.